These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. The effects of fibrates on lipoprotein and hemostatic coronary risk factors. Schonfeld G Atherosclerosis; 1994 Dec; 111(2):161-74. PubMed ID: 7718018 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of ciprofibrate in hyperlipoproteinaemias. Turpin G; Bruckert E Atherosclerosis; 1996 Jul; 124 Suppl():S83-7. PubMed ID: 8831920 [TBL] [Abstract][Full Text] [Related]
39. A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al. Davidson MH Cardiovasc Drugs Ther; 2009 Oct; 23(5):341-2. PubMed ID: 19844785 [No Abstract] [Full Text] [Related]
40. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]